Varying outcomes of triple-negative breast cancer in different age groups–prognostic value of clinical features and proliferation

PURPOSE: Triple-negative breast cancer (TNBC) is an aggressive disease lacking specific biomarkers to guide treatment decisions. We evaluated the combined prognostic impact of clinical features and novel biomarkers of cell cycle-progression in age-dependent subgroups of TNBC patients. METHODS: One h...

Descripción completa

Detalles Bibliográficos
Autores principales: Vihervuori, H., Korpinen, K., Autere, T. A., Repo, H., Talvinen, K., Kronqvist, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Preclinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633490/
https://www.ncbi.nlm.nih.gov/pubmed/36261751
http://dx.doi.org/10.1007/s10549-022-06767-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633490/
https://www.ncbi.nlm.nih.gov/pubmed/36261751
http://dx.doi.org/10.1007/s10549-022-06767-1

Ejemplares similares